Health Care: Drugs

Sinovac Biotech Ltd (SVA: NASDAQ)

$5.85 n/a | n/a%
07/28/16 - 04:00 PM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 67.41M 63.10M 72.52M 49.22M
Cost of Sales 11.79M 7.96M 14.43M 15.97M
Gross Operating Profit 55.62M 55.14M 58.09M 33.24M
Selling, General, and Administrative Expenses 37.39M 35.12M 34.03M 30.81M
Research & Development 9.49M 11.03M 8.38M 17.04M
Operating Income before D & A (EBITDA) 8.74M 8.99M 15.68M -14.61M
Depreciation & Amortization 6.63M 8.53M 6.84M 4.72M
Interest Income 1.16M 2.69M 2.17M 2.37M
Other Income - Net 1.68M 1.36M 263.00K -851.57K
Special Income / Charges 0.00 30.00K -88.00K -1.82M
Total Income Before Interest Expenses (EBIT) 4.95M 4.53M 11.18M -19.63M
Interest Expense 1.92M 3.41M 3.03M 0.00
Pre-Tax Income 3.03M 1.12M 8.14M -19.63M
Income Taxes 2.52M 1.46M -2.23M -883.90K
Minority Interest 861.00K 515.00K 2.93M -3.90M
Net Income From Continuing Operations 515.00K -336.00K 10.37M -18.75M
Net Income From Discontinued Operations -728.00K 0.00 0.00 0.00
Net Income From Total Operations -213.00K -336.00K 10.37M -18.75M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -1.07M -851.00K 7.44M -14.85M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
515.00K -366.00K 10.46M -16.93M
Preferred Dividends
Net Income Available To Common 515.00K -336.00K 10.37M -18.75M
Basic EPS from Continuing Ops. -0.01 -0.02 0.13 -0.27
Basic EPS from Discontinued Ops. -0.01 0.00 0.00 0.00
Basic EPS from Total Operations -0.02 -0.02 0.13 -0.27
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.02 -0.02 0.13 -0.27
Basic Normalized Net Income/Share n.a. -0.02 0.13 -0.24
EPS fr Continuing Ops. -0.01 -0.02 0.13 -0.27
EPS fr Discontinued Ops -0.01 0.00 0.00 0.00
EPS fr Total Ops. -0.02 -0.02 0.13 -0.27
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.02 -0.02 0.13 -0.27
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
n.a. -0.02 0.13 -0.24
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with SVA

Latest SVA Headlines from TheStreet

More Financial News for SVA

Press Releases for SVA

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter